Zobrazeno 1 - 10
of 93
pro vyhledávání: '"Yatani, Ryuichi"'
Autor:
Nakayama, Tsuyoshi, Watanabe, Masatoshi, Yamanaka, Mikio, Hirokawa, Yoshifumi, Suzuki, Hiroyoshi, Ito, Haruo, Yatani, Ryuichi, Shiraishi, Taizo
Publikováno v:
In Laboratory Investigation 1 July 2001 81(7):1049-1057
Autor:
Nakayama, Tsuyoshi, Watanabe, Masatoshi, Suzuki, Hiroyoshi, Toyota, Minoru, Sekita, Nobuyuki, Hirokawa, Yoshifumi, Mizokami, Atsushi, Ito, Haruo, Yatani, Ryuichi, Shiraishi, Taizo
Publikováno v:
In Laboratory Investigation 1 December 2000 80(12):1789-1796
Autor:
Watanabe, Masatoshi *, Nakayama, Tsuyoshi, Shiraishi, Taizo, Stemmermann, Grant N, Yatani, Ryuichi
Publikováno v:
In Urologic Oncology: Seminars and Original Investigations 2000 5(6):274-283
Publikováno v:
In Human Pathology 1999 30(1):105-108
Autor:
Watanabe, Hiroki, Ohe, Hiroshi, Nakagawa, Shuichi, Takada, Hitoshi, Ebisui, Koji, Hirayama, Takeshi, Aoki, Kunio, Watanabe, Sho, Minowa, Masumi, Yatani, Ryuichi, Masuda, Fujio, Satomi, Yoshiaki, Mishina, Teruo, Tsuchihashi, Yasunari
Publikováno v:
泌尿器科紀要. 38(2):237-253
A workshop on the high risk group and the preventive oncology of renal cell carcinoma was held in Kyoto on September 7, 1990. The following subjects were presented: 1. Cohort study of renal cell carcinoma (Dr. Hirayama). 2. Pathoepidemiological study
Autor:
Hioki, Takuichi, Sugimura, Yoshiki, Sakurai, Masaki, Hayashi, Norio, Tochigi, Hiromi, Kawamura, Juichi, Yatani, Ryuichi
Publikováno v:
泌尿器科紀要. 36(8):921-926
前立腺癌ではGSが予後とよく相関するとして欧米で用いられ, 一方, 本邦では1985年に前立腺癌取扱い規約において独自の組織分類法(規約分類)が提唱され, 以下両者を比較した.規約分類とG
Publikováno v:
泌尿器科紀要. 36(6):667-671
1971年より1987年までに千葉大学泌尿器科において内分泌療法を施行したstage D2前立腺癌175例のうち, 5年以上制癌状態のもの18例と, 治療に反応せず, あるいは当初制癌されたが再燃し3年以
Autor:
Ioshii, Sérgio Ossamu, Sakamoto, Danielle Giacometti, Machuca, Tiago Noguchi, Yatani, Ryuichi
Publikováno v:
Sao Paulo Medical Journal, Volume: 122, Issue: 5, Pages: 172-174, Published: 2004
CONTEXT: Inflammatory pseudotumor is a rare benign lesion that can occur at a wide variety of primary sites. It is usually worrisome for the patient and the medical staff, since it cannot be clinically or radiologically distinguished from malignant e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______608::1fe2a2b790c29bc7db88009f1452781e
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802004000500008&lng=en&tlng=en
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802004000500008&lng=en&tlng=en
Autor:
Konishi, Noboru, Hiasa, Yoshio, Matsuda, Hirofumi, Tao, Ming, Tsuzuki, Toshihide, Hayashi, Isao, Kitahori, Yoshiteru, Shiraishi, Taizo, Yatani, Ryuichi, Shimazaki, Jun, Lin, Jung-Chung
To assess the potential role of ras oncogene activation and p53 tumor suppressor gene mutations in the development of human prostate carcinoma, nine cases of histologically heterogeneous prostate tumors obtained from total prostatectomies were probed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a543ac1466f983f0ee0ddfe69d46d7a9
https://europepmc.org/articles/PMC1871010/
https://europepmc.org/articles/PMC1871010/
Autor:
Akira Komiya, Takeshi Ueda, Chiba Shiraishi Taizo, Haruo Ito, Yuzo Furuya, Yatani Ryuichi, Hiroyoshi Suzuki
Publikováno v:
The Journal of Urology. :55